ATT-myc	Alpha-1-antitrypsin-c-myc transgenic model
Abl	Abelson murine leukemia oncogene 1
Bag3	family molecular chaperone regulator 3
C/ebpa,b	CCAAT/enhancer-binding protein alpha, beta
C-Abl	Tyrosine kinase ABL1
Casp3	Caspase 3
Casp8	Caspase 8
Casp9	caspase 9
Cav-1	Caveolin-1
CMet	Hepatocyte growth factor receptor
Col1a1	Collagen 1a1
EGF	Epidermal growth factor
EGFR	Epidermal growth factor receptor
ERKs	Extracellular-signal-regulated kinases
FAK	Focal Adhesion Kinase
FAS (CD95)	FAS-legand apoptosis pathway
HGF	Hepatocyte growth factor
HGFA	Hepatocyte growth factor activator
HNF	Hepatocyte nuclear factor
HSC	hepatocyte stellate cells
IGF1	Insulin-like growth factor 1
Ikkb	inhibitor of nuclear factor kappa-B kinase subunit beta
INTGα1	Integrin alpha1
INTGβ1	Integrin Beta 1
Jnk	C-Jun N-terminal kinases
Nek 6	NIMA (never in mitosis)-related kinase 6
NF-kb	nuclear factor kappa-light-chain-enhancer of activated B
Ntr	non-transgenic or wild
PAI-1	Plasminogen activator inhibitor-1
Pparα	Peroxisome proliferator-activated receptor alpha
Pparγ	Peroxisome proliferator-activated receptor gamma
SOD1	Superoxide dismutase
Src	Rous sarcoma oncogene
TF	Transcription factor
Tr	transgenic
ntr	Non-transgenic
TGFa	Transforming growth factor alpha
TGFb1	Transforming growth factor beta 1
TGFbr2	Transforming growth factor beta receptor 2
TNF-r1	tumor necrosis superfamily receptor 1
BHT_4_m_tr	BHT-treated mice for fourth sacrifice or 8.5 months, male, transgenic
BHT_4_f_tr	BHT-treated mice for fourth sacrifice or 8.5 months, female, transgenic
DEN_4_m_tr	DEN-treated mice for fourth sacrifice or 8.5 months, male, transgenic
DEN_4_f_tr	DEN-treated mice for fourth sacrifice or 8.5 months, female, transgenic
Co_4_m_ntr	Comparison with male non-transgenic mice as a background
Co_4_m_tr	Comparison with male transgenic mice as a background
Co_4_f_tr	Comparison with female transgenic mice as a background